Dawei Li - Dec 29, 2023 Form 3 Insider Report for Li-Cycle Holdings Corp. (LICY)

Role
Regional President, APAC
Signature
/s/ Carl DeLuca, attorney-in-fact on behalf of Dawei Li
Stock symbol
LICY
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
3
Date filed
12/29/2023, 04:45 PM
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LICY Common Shares 72.9K Dec 29, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LICY Employee Stock Option (right to buy) Dec 29, 2023 Common Shares 18.7K $10.93 Direct F2
holding LICY Employee Stock Option (right to buy) Dec 29, 2023 Common Shares 31.7K $13.20 Direct F3
holding LICY Employee Stock Option (right to buy) Dec 29, 2023 Common Shares 18.9K $7.58 Direct F4
holding LICY Employee Stock Option (right to buy) Dec 29, 2023 Common Shares 31.5K $5.77 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 43,861 restricted stock units ("RSUs") awarded to the reporting person under the Li-Cycle Holdings Corp. 2021 Incentive Award Plan. Each RSU represents the contingent right to receive one common share of Li-Cycle Holdings Corp subject to time-vesting conditions in accordance with the underlying award and the reporting person's continued service through such vesting date.
F2 The stock option became exercisable as to 6,237 common shares on August 10, 2022 and 6,238 common shares on August 10, 2023. The stock option becomes exercisable as to the remaining 6,237 common shares on August 10, 2024.
F3 The stock option became exercisable as to 10,575 common shares on November 22, 2022 and 10,575 common shares on November 22, 2023. The stock option becomes exercisable as to the remaining 10,575 common shares on November 22, 2024.
F4 The stock option became exercisable as to 6,316 common shares on January 31, 2023. The stock option becomes exercisable as to 6,315 common shares on January 31, 2024 and 6,316 common shares on January 31, 2025.
F5 The stock option becomes exercisable as to 10,496 common shares on January 27, 2024, 10,496 common shares on January 27, 2025 and 10,496 common shares on January 27, 2026.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney This Form 3 is being filed because, beginning January 1, 2024, the Issuer will no longer be eligible to use the forms and rules designated by the Securities and Exchange Commission for foreign private issuers (as defined in Rule 3b-4 of the Securities Exchange Act of 1934, as amended).